{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:35:31Z","timestamp":1790202931333,"version":"4.1.0"},"reference-count":34,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.3892\/mmr.2015.3707","type":"journal-article","created":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T08:39:43Z","timestamp":1430383183000},"page":"2757-2764","source":"Crossref","is-referenced-by-count":29,"title":["Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: A report of three cases"],"prefix":"10.3892","volume":"12","author":[{"given":"TORU","family":"ISHIBASHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MIKI","family":"ICHIKAWA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BUNPEI","family":"SATO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHINJI","family":"SHIBATA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUICHI","family":"HARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUJI","family":"NARITOMI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KEN","family":"OKAZAKI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YASUHARU","family":"NAKASHIMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUKIHIDE","family":"IWAMOTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SAMON","family":"KOYANAGI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIROSHI","family":"HARA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TETSUHIKO","family":"NAGAO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,30]]},"reference":[{"key":"key20180108022138_b1-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMra041320","article-title":"Psoriasis","volume":"352","author":"Schon","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180108022138_b2-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N Engl J Med"},{"key":"key20180108022138_b3-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.4049\/jimmunol.0803721","article-title":"IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells","volume":"183","author":"Goodman","year":"2009","journal-title":"J Immunol"},{"key":"key20180108022138_b4-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17 and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediators Inflamm"},{"key":"key20180108022138_b5-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0923-1811(96)00562-2","article-title":"Role of increased production of monocytes TNF-alpha, IL-1beta and IL-6 in psoriasis: relation to focal infection, disease activity and responses to treatments","volume":"14","author":"Mizutani","year":"1997","journal-title":"J Dermatol Sci"},{"key":"key20180108022138_b6-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/jid.2012.194","article-title":"The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings","volume":"133","author":"Martin","year":"2013","journal-title":"J Invest Dermatol"},{"key":"key20180108022138_b7-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdermsci.2010.03.023","article-title":"Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis-a possible target for novel therapies?","volume":"58","author":"Canavese","year":"2010","journal-title":"J Dermatol Sci"},{"key":"key20180108022138_b8-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jaci.2009.08.046","article-title":"Effective treatment of psoriasis with etanercept is linked to suppression of IL-17 signaling, not immediate response TNF genes","volume":"124","author":"Zaba","journal-title":"J Allergy Clin Immunol"},{"key":"key20180108022138_b9-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(00)04954-0","article-title":"Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial","volume":"357","author":"Chaudhari","year":"2001","journal-title":"Lancet"},{"key":"key20180108022138_b10-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1365-2133.2008.08455.x","article-title":"Severe exacerbation of chronic plaque psoriasis following initially effective therapy with efalizumab: clinical characterization and therapeutic management","volume":"158","author":"Ulmer","year":"2008","journal-title":"Br J Dermatol"},{"key":"key20180108022138_b11-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.freeradbiomed.2009.06.033","article-title":"Oxidative stress in the pathogenesis of psoriasis","volume":"47","author":"Zhou","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"key20180108022138_b12-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00403-012-1230-8","article-title":"Role of cellular oxidative stress and cytochrome c in the pathogenesis of psoriasis","volume":"304","author":"Gabr","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"key20180108022138_b13-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"key20180108022138_b14-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"6375","DOI":"10.2174\/13816128113199990507","article-title":"Molecular hydrogen: new antioxidant and anti-inflammatory therapy for rheumatoid arthritis and related diseases","volume":"19","author":"Ishibashi","year":"2013","journal-title":"Curr Pharm Des"},{"key":"key20180108022138_b15-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/jid.2011.45","article-title":"Fumarate esters as angiogenesis inhibitors: key to action in psoriasis?","volume":"131","author":"Arbiser","year":"2011","journal-title":"J Invest Dermatol"},{"key":"key20180108022138_b16-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"11783","DOI":"10.3390\/ijms130911783","article-title":"Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters","volume":"13","author":"Lee","year":"2012","journal-title":"Int J Mol Sci"},{"key":"key20180108022138_b17-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nm1577","article-title":"Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals","volume":"13","author":"Ohsawa","year":"2007","journal-title":"Nat Med"},{"key":"key20180108022138_b18-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0764-4469(01)01350-6","article-title":"Anti-inflammatory properties of molecular hydrogen: investigation on parasite-induced liver inflammation","volume":"324","author":"Gharib","year":"2001","journal-title":"C R Acad Sci III"},{"key":"key20180108022138_b19-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"353152","DOI":"10.1155\/2012\/353152","article-title":"Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases","volume":"2012","author":"Ohno","year":"2012","journal-title":"Oxid Med Cell Longev"},{"key":"key20180108022138_b20-mmr-12-02-2757","first-page":"554","article-title":"Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society","volume":"28","author":"Hukuda","year":"2001","journal-title":"J Rheumatol"},{"key":"key20180108022138_b21-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/2045-9912-2-27","article-title":"Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study","volume":"2","author":"Ishibashi","year":"2012","journal-title":"Med Gas Res"},{"key":"key20180108022138_b22-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-9912-2-21","article-title":"A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level","volume":"2","author":"Ono","year":"2012","journal-title":"Med Gas Res"},{"key":"key20180108022138_b23-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2045-9912-1-12","article-title":"Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled study","volume":"1","author":"Ono","year":"2011","journal-title":"Med Gas Res"},{"key":"key20180108022138_b24-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/2045-9912-2-14","article-title":"Hydrogen (H2) treatment for acute erythematous skin diseases. A report of 4 patients with safety data and a non-controlled feasibility study with H2 concentration measurement on two volunteers","volume":"2","author":"Ono","year":"2012","journal-title":"Med Gas Res"},{"key":"key20180108022138_b25-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1152\/jappl.1994.76.3.1113","article-title":"Psychophysiological reactions in humans during an open sea dive to 500 m with a hydrogen-helium-oxygen mixture","volume":"76","author":"Abraini","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"key20180108022138_b26-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2045-9912-2-1","article-title":"A convenient method for determining the concentration of hydrogen in water: use of methylene blue with colloidal platinum","volume":"2","author":"Seo","year":"2012","journal-title":"Med Gas Res"},{"key":"key20180108022138_b27-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2133.1997.tb03819.x","article-title":"The psoriasis area and severity index and alternative approaches for the assessment of severity: persisting areas of confusion","volume":"137","author":"van de Kerkhof","year":"1997","journal-title":"Br J Dermatol"},{"key":"key20180108022138_b28-mmr-12-02-2757","first-page":"84","article-title":"Psoriasis affects patient\u2019s quality of life more seriously in female than in male in Japan","volume":"37","author":"Mabuchi","year":"2012","journal-title":"Tokai J Exp Clin Med"},{"key":"key20180108022138_b29-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"key20180108022138_b30-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/03009749609104058","article-title":"Clinical assessment of the 1987 American College of Rheumatology criteria for rheumatoid arthritis","volume":"25","author":"Levin","year":"1996","journal-title":"Scand J Rheumatol"},{"key":"key20180108022138_b31-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2340\/00015555-0851","article-title":"Pruritus is an important factor negatively influencing the well-being of psoriatic patients","volume":"90","author":"Reich","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"key20180108022138_b32-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1111\/j.1365-2133.2007.07916.x","article-title":"Prevalence of physical symptoms of itch, pain and fatigue in patients with skin diseases in general practice","volume":"156","author":"Verhoeven","year":"2007","journal-title":"Br J Dermatol"},{"key":"key20180108022138_b33-mmr-12-02-2757","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1749-6632.2009.04652.x","article-title":"NGF and its receptor system: a new dimension in the pathogenesis of psoriasis and psoriatic arthritis","volume":"1173","author":"Raychaudhuri","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"key20180108022138_b34-mmr-12-02-2757","first-page":"13","article-title":"Clinical and experimental aspects of cutaneous neurogenic inflammation","volume":"58","author":"Zegarska","year":"2006","journal-title":"Pharmacol Rep"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2015.3707\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T04:22:53Z","timestamp":1515385373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2015.3707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,30]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,30]]},"published-print":{"date-parts":[[2015,8]]}},"alternative-id":["10.3892\/mmr.2015.3707"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2015.3707","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,30]]}}}